Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Consolidation Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Early research (Phase 1)UnknownNCT06187740
What this trial is testing

Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapy

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Fudan University 28
Testing effectiveness (Phase 2)WithdrawnNCT03574649
What this trial is testing

QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
ImmunityBio, Inc.
Early research (Phase 1)Study completedNCT04634435
What this trial is testing

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT03033303
What this trial is testing

The Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 59
Testing effectiveness (Phase 2)Looking for participantsNCT07575919
What this trial is testing

Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Liping Dou 20
Testing effectiveness (Phase 2)Study completedNCT05758116
What this trial is testing

Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients

Who this might be right for
Non-small Cell Lung CancerConsolidation ImmunotherapyRadiotherapy or Sequential Chemoradiation
Peking University Cancer Hospital & Institute 5
Very early researchLooking for participantsNCT03719105
What this trial is testing

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

Who this might be right for
NK-Cell LymphomaNK-Cell LeukemiaPeripheral T Cell Lymphoma
New York Medical College 40